Utilization of Interventional Oncology Treatments in the United States

Journal of Vascular and Interventional Radiology

Volumn 21, Issue 7, 2010, Pages 1054-1060

  Kwan, Sharon W ^a   Kerlan Jr , Robert K ^a   Sunshine, Jonathan H ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b AMERICAN COLLEGE OF RADIOLOGY   (United States)

^c YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ARTIFICIAL EMBOLISM; CANCER SURGERY; CANCER THERAPY; HEALTH SERVICE; HUMAN; KIDNEY CANCER; KIDNEY TUMOR; LIVER CANCER; PRIORITY JOURNAL; UNITED STATES;

CATHETER ABLATION; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; MALE; NEOPLASMS; PREVALENCE; RADIOGRAPHY, INTERVENTIONAL; UNITED STATES; UTILIZATION REVIEW;

EID: 77953872188     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2010.02.028     Document Type: Article

References (27)

1. Lencioni R.A., Allgaier H., Cioni D., et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 228 (2003) 235-240
2. Zhang Y., Liang H., Chen M., et al. Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial. Radiology 244 (2007) 599-607
3. Hegarty N.J., Gill I.S., Desai M.M., Remer E.M., O'Malley C.M., and Kaouk J.H. Probe-ablative nephron-sparing surgery: cryoablation versus radiofrequency ablation. Urology 68 (2006) 7-13
4. Zagoria R.J., Traver M.A., Werle D.M., Perini M., Hayasaka S., and Clark P.E. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol 189 (2007) 429-436
5. Woertler K., Vestring T., Boettner F., Winkelmann W., Heindel W., and Lindner N. Osteoid osteoma: CT-guided percutaneous radiofrequency ablation and follow-up in 47 patients. J Vasc Interv Radiol 12 (2001) 717-722
6. Graziadei I.W., Sandmueller H., Waldenberger P., et al. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl 9 (2003) 557-563
7. Belghiti J., Carr B., Greig P., Lencioni R., and Poon R. Treatment before liver transplantation for HCC. Ann Surg Oncol 15 (2008) 993-1000
8. Chapman W.C., Majella Doyle M.B., Stuart J.E., et al. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation. Ann Surg 248 (2008) 617-625
9. Yao F.Y., Hirose R., LaBerge J.M., et al. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl 11 (2005) 1505-1514
10. Lo C., Ngan H., Tso W., et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35 (2002) 1164-1171
11. Llovet J.M., Real M.I., Montaña X., et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359 (2002) 1734-1739
12. Belfiore G., Moggio G., Tedeschi E., et al. CT-guided radiofrequency ablation: a potential complementary therapy for patients with unresectable primary lung cancer-a preliminary report of 33 patients. AJR Am J Roentgenol 183 (2004) 1003-1011
13. Goetz M.P., Callstrom M.R., Charboneau J.W., et al. Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol 22 (2004) 300-306
14. Nguyen C.T., Campbell S.C., and Novick A.C. Choice of operation for clinically localized renal tumor. Urol Clin North Am 35 (2008) 645-655
15. Rosenthal D.I. Radiofrequency treatment. Orthop Clin North Am 37 (2006) 475-484
16. Khan N., Murphy T.P., Soares G.M., and Zahir I.S. Clinical services provided by interventional radiologists to Medicare beneficiaries in the United States, 2000-2003. J Vasc Interv Radiol 16 (2005) 1753-1757
17. Centers for Medicare and Medicaid Services. 2009 Medicare Trustees Report. Baltimore: Centers for Medicare and Medicaid Services, 2009; 37
18. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program, SEER*Stat Database. http://seer.cancer.gov/statistics/ Accessed November 11, 2009
19. Sunshine J.H., Lewis R.S., and Bhargavan M. A portrait of interventional radiologists in the United States. AJR Am J Roentgenol 185 (2005) 1103-1112
20. Maxwell N.J., Saleem Amer N., Rogers E., Kiely D., Sweeney P., and Brady A.P. Renal artery embolisation in the palliative treatment of renal carcinoma. Br J Radiol 80 (2007) 96-102
21. Schwartz M.J., Smith E.B., Trost D.W., and Vaughan E.D. Renal artery embolization: clinical indications and experience from over 100 cases. BJU Int 99 (2007) 881-886
22. Wallace S., Chuang V.P., Swanson D., et al. Embolization of renal carcinoma. Radiology 138 (1981) 563-570
23. Bono A.V., and Caresano A. The role of embolization in the treatment of kidney carcinoma. Eur Urol 9 (1983) 334-337
24. Lam J.S., Shvarts O., and Pantuck A.J. Changing concepts in the surgical management of renal cell carcinoma. Eur Urol 45 (2004) 692-705
25. Poon D., Anderson B.O., Chen L., et al. Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol 10 (2009) 1111-1118
26. Wong S.L., Mangu P.B., Choti M.A., et al. American society of clinical oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol 28 (2010) 493-508
27. Mulier S., Ruers T., Jamart J., Michel L., Marchal G., and Ni Y. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? An update. Dig Surg 25 (2008) 445-460